UP Manila | Online ISSN 2094-9278
Submit an Article Login Register

CD14/-159 and TNF?/-308 Promoter Polymorphisms are not associated with Development of Idiopathic Neonatal Hepatitis among Filipinos

Authors

  • Florence Giannina F. San Juan
  • Annavi Marie G. Villanueva
  • Germana Emerita V. Gregorio
  • Catherine Lynn T. Silao

DOI:

https://doi.org/10.47895/amp.v51i3.553

Keywords:

Idiopathic neonatal hepatitis CD14 TNFα promoter polymorphism Filipino

Abstract

Objective. To determine if the CD14/-159 and the TNF?/-308 single nucleotide polymorphisms (SNPs) are associated with the development of Idiopathic Neonatal Hepatitis (INH) in Filipino children.

Methods. Genomic DNA from 33 patients diagnosed with INH and 33 age- and sex-matched controls, children without any liver disease, were recruited. Baseline serum total bilirubin (TB), direct bilirubin (DB), and alkaline phosphatase (ALP) of the patients were obtained from their medical records. Genotypes for CD14/159 and TNF?/-308 were determined via PCR and direct sequencing.

Results. No significant difference was seen between the frequency of the CD14/-159 T allele (p=0.86) nor the TNF?/-308 A allele (p=0.62) between INH patients and controls. There was also no significant difference between the genotypic distribution of the INH and control populations for both CD14/-159 (p=0.54) and TNF?/-308 (p=0.62). There were also no significant differences noted between the different genotypes of CD14/159 and TNF?/-308 and levels of alkaline phosphatase (p=0.65, p=0.91), total bilirubin (p=0.89, p=0.75), and direct bilirubin (p=0.93, p=0.68).

Conclusion. In this preliminary study, CD14/-159 and TNF?/-308 showed no association with the development of INH among Filipinos.

References

Most read articles by the same author(s)

1 2 3 4 > >> 

Similar Articles

1-10 of 1139

You may also start an advanced similarity search for this article.

Shape the Future of Philippine Medicine

Become a Peer Reviewer for Acta Medica Philippina — join a growing community of experts advancing Philippine medical research.

Apply Now